Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
Journalists
Submit Release
January 24, 2009
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Websites.
 
Close Move
All Press Releases for March 29, 2008 Subscribe to this News Feed    
 

Announcing a New Medical-education Based Preferred Stock-analysis Website - TradeRXchange.com

TradeRXchange.com was founded by Scott B. Freeman M.D. along with co-founder Scott Conoly M.D. We offer financial consultation on the gambit of today's most dynamic life-science equities. Using an education-based approach, TradeRXchange.com's readers will hear from those with direct experience with healthcare products and services. This allows you to better understand the investment potential of the company's behind them. Specifically, subscribers can request specific consultation on our coverage space, have access to TradeRXchange.com's own watchlist, and hear from biotechnology, pharmaceutical, medical device, and physiometric business leaders in the United States and around the globe.

(Web.com/PRWEB ) March 29, 2008 -- TradeRXchange.com will provide an utterly unique resource for those trading in the life-science sector. Our objective is not only to improve your bottom line, but to give you piece of mind in your investment decisions. The e-journal is in its formative stage currently, and is freely acceptable. However, as the content blue-print is realized, it will become a competitive tool in any investor's repartee.

Already featured in its first week, an exclusive interview with Dr. Kohkan Shamsi, CEO of Acunova. Acunova is a Contract Research Organization (CRO), in India's emerging tech sector. Also, our March journal watch shed some light on the fate of Aspect Medical's white knight - the BIS monitor. Coming soon, a journal watch you can't afford to miss and finally, the watchlist. TradeRXchange.com has been monitoring its watchlist for approximately two years. One of its featured equities, Encysive Pharmaceuticals, recently purchased by Pfizer for over 200% of its share value. This was anticipated by our research team reviewing the content and status of its pipeline, which as Pfizer's analysts agreed, has great upside potential. TradeRXchange.com is building its upside portfolio right now, please visit the website and contact us with questions and comments.

www.TradeRXchange.com is staffed exclusively by M.D's, PhD's, and MBA's. It will offer everything including interviews with business and clinical leaders, comprehensive surveillance of Medical Journals and Clinical Trial information, as well as telephonic consultation on specific healthcare products and services.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3VtbS1TcXVhLUhvcnItSGFsZi1TdW1tLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Scott Conoly
TradeRXchange
832-203-7904
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2009, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright